Richard Liu and Joaquin Duato lead work associated with very different organisational histories. Liu is JD.com’s founder and chairman; Duato is Johnson & Johnson’s chairman and CEO. The presence of healthcare-related businesses within a wider commerce group can make the pair seem especially connected, but company names and commercial relationships must be checked carefully. This guide separates founder status, executive office and the evidence required for any claimed partnership.
Richard Liu’s current role needs precise wording
JD.com’s management information identifies Richard Qiangdong Liu as its founder and chairman. The fuller name helps distinguish the executive from other people called Richard Liu. It also makes the company’s own record easier to locate and assess.
Liu ceased serving as JD.com’s chief executive in April 2022. A founder can retain an important governance position after leaving the CEO office, but the two titles are not interchangeable. Describing him simply as the current CEO would conceal a significant leadership transition.
The founder-chairman distinction is useful beyond this one biography. Founding a company is a historical relationship to its creation. Chairing its board is an ongoing governance responsibility. Running its operations as CEO is another role again. One person can hold several of those positions, but a profile should state which roles apply at the time being discussed.
Commerce and logistics shape JD.com’s context
JD.com’s corporate structure includes businesses operating in different areas, with logistics and health among the activities associated with the wider group. The company’s board information helps place Liu’s role within that structure. A reader should nevertheless distinguish the listed company, related businesses and the individual executive.
Digital commerce involves more than a website displaying products. Ordering systems, warehouses, delivery networks, customer service and seller relationships all affect how a business operates. Those general features explain why a commerce leader can be discussed in relation to infrastructure and access.
They do not, however, establish that a particular healthcare manufacturer has a distribution contract with the group. A plausible business fit is not evidence of an actual agreement. Any claim about named products or a commercial partnership would need a dated announcement describing the participating entities and the terms relevant to the report.
JD Health and Johnson & Johnson are not the same organisation
The words “health” and “healthcare” cover a wide range of activities. A service helping people obtain products or information performs a different function from an organisation developing medicines or medical technology. A comparison should identify the activity before making claims about who does what.
JD Health is not another name for Johnson & Johnson. Nor does Liu’s role within the JD group make him a J&J executive. Keeping the legal and organisational identities distinct prevents a reader from mistaking an industry comparison for a report of common ownership.
Duato’s work belongs to the leadership of Johnson & Johnson. The useful analytical question is how different organisations contribute to complex systems of supply, service and expertise. That discussion can proceed without inventing a personal relationship between the executives or attributing an unverified agreement to their companies.
Richard Liu and Joaquin Duato: what connection is established?
The primary sources reviewed establish the two men’s separate leadership roles. They do not establish a specific Liu–Duato joint venture or a named distribution agreement for the purposes of this article. That limited conclusion should not be expanded into a claim about every transaction involving large international companies.
A strong report of collaboration would identify the exact corporate entities, the announcement date and the work undertaken. Until such evidence is supplied, this article treats the pair as a comparison of commerce and healthcare leadership. The featured image is a separately sourced interview still and portrait, not a shared appearance.
Joaquin Duato’s role at Johnson & Johnson
Joaquin Duato leads Johnson & Johnson as chairman and chief executive officer. His appointment as CEO took effect on 3 January 2022, and he became chairman in January 2023. Those are separate leadership milestones: the chief executive runs the business, while the chairman leads its board. The distinction matters when comparing him with a founder, a former executive or a public figure whose influence comes from creative work.
Johnson & Johnson’s present business centres on Innovative Medicine and MedTech. Its work spans medicines, medical technology and the organisations needed to research, manufacture and supply them. Duato’s responsibilities therefore involve scientific investment, operating decisions and corporate governance. They should not be confused with practising medicine or personally developing every treatment sold by the company.
The company’s own leadership biography provides the starting point for identifying him. For the timing of his leadership transition, its chairman appointment announcement is more precise than an undated profile. A reliable comparison keeps those dated corporate records separate from assumptions prompted by two names appearing together.
At a glance: Richard Liu and Joaquin Duato
| Point of comparison | Richard Liu | Joaquin Duato |
|---|---|---|
| Organisation | JD.com | Johnson & Johnson |
| Role discussed | Founder and chairman | Chairman and CEO |
| Industry comparison | Commerce, logistics and related services | Medicine and MedTech |
The table summarises the roles discussed in this guide; it does not suggest that the subjects hold equivalent positions. Historical appointments, current responsibilities and public recognition should be assessed within their own institutions. Where a title has changed, the dated source takes precedence over an older introduction.
Frequently asked questions
What is Richard Liu’s fuller professional name?
JD.com identifies him as Richard Qiangdong Liu. The fuller name helps distinguish him from namesakes.
Is he still JD.com’s CEO?
He ceased serving as CEO in April 2022. Founder and chairman are separate roles from chief executive.
Is JD Health the same as Johnson & Johnson?
No. The organisations have distinct identities. A shared healthcare theme does not establish common ownership or a specific commercial agreement.
Related reading
For another comparison of healthcare leadership, read our guide to Joaquin Duato and Robert Davis. Our article on Joaquin Duato and Margot Robbie provides a separate example of how public careers can be examined without assuming a shared project.
Sources and image context
This guide was checked on 20 October 2026 against the institutional sources linked in the text. A source verifies the particular role, date or achievement attributed to it; it does not automatically verify a relationship between everyone discussed. Photograph credits and original licences appear in the captions.
The featured image is an OrbitNews editorial composite made from separate source images. It is not a photograph of a shared meeting or event. Images were cropped and arranged within the black frame with its red circular inset and original brand logo. The photographic adaptation is available under CC BY-SA 4.0, with original credits retained and trademarks belonging to their owners.
